Hedge Fund - OrbiMed Advisors
Boston Scientific Corp (BSX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q4 (2023-12-31) | $191,166,108 | 3.81% | 3,306,800 | $53.38 |
| 2 | 2023 - Q3 (2023-09-30) | $174,599,040 | 3.7% | 3,306,800 | $52.45 |
| 3 | 2023 - Q2 (2023-06-30) | $182,818,791 | 3.31% | 3,379,900 | $52.23 |
| 4 | 2023 - Q1 (2023-03-31) | $189,613,700 | 3.72% | 3,790,000 | $47.13 |
| 5 | 2022 - Q4 (2022-12-31) | $180,369,714 | 3.45% | 3,898,200 | $43.30 |
| 6 | 2022 - Q3 (2022-09-30) | $150,977,000 | 2.8% | 3,898,200 | $40.12 |
| 7 | 2022 - Q2 (2022-06-30) | $162,851,000 | 2.95% | 4,369,500 | $40.71 |
| 8 | 2022 - Q1 (2022-03-31) | $203,712,000 | 3.3% | 4,599,500 | $43.34 |
| 9 | 2021 - Q4 (2021-12-31) | $235,862,000 | 3.03% | 5,552,300 | $42.02 |
| 10 | 2021 - Q3 (2021-09-30) | $253,120,000 | 2.78% | 5,833,600 | $44.24 |
| 11 | 2021 - Q2 (2021-06-30) | $295,925,000 | 2.99% | 6,920,600 | $42.07 |
| 12 | 2021 - Q1 (2021-03-31) | $267,481,000 | 2.5% | 6,920,600 | $37.85 |
| 13 | 2020 - Q4 (2020-12-31) | $234,502,000 | 2.05% | 6,523,000 | $36.04 |
| 14 | 2020 - Q3 (2020-09-30) | $185,215,000 | 2.32% | 4,847,300 | $38.53 |
| 15 | 2020 - Q2 (2020-06-30) | $170,189,000 | 2.39% | 4,847,300 | $36.01 |
| 16 | 2020 - Q1 (2020-03-31) | $158,167,000 | 2.65% | 4,847,300 | $39.07 |
| 17 | 2019 - Q4 (2019-12-31) | $211,394,000 | 3.01% | 4,674,800 | $41.84 |
| 18 | 2019 - Q3 (2019-09-30) | $214,383,000 | 4.06% | 5,268,700 | $42.37 |
| 19 | 2019 - Q2 (2019-06-30) | $290,222,000 | 4.49% | 6,752,500 | $38.46 |
| 20 | 2019 - Q1 (2019-03-31) | $222,236,000 | 3.44% | 5,790,400 | $38.19 |
| 21 | 2018 - Q4 (2018-12-31) | $204,633,000 | 3.78% | 5,790,400 | $36.27 |
| 22 | 2018 - Q3 (2018-09-30) | $302,764,000 | 3.64% | 7,863,995 | $34.93 |
| 23 | 2018 - Q2 (2018-06-30) | $313,093,000 | 3.73% | 9,574,695 | $30.16 |
| 24 | 2018 - Q1 (2018-03-31) | $283,521,000 | 3.51% | 10,377,795 | $27.18 |
| 25 | 2017 - Q4 (2017-12-31) | $257,484,000 | 3.25% | 10,386,600 | $27.58 |
| 26 | 2017 - Q3 (2017-09-30) | $390,790,000 | 3.73% | 13,397,000 | $27.62 |
| 27 | 2017 - Q2 (2017-06-30) | $399,168,000 | 4.18% | 14,400,000 | $26.54 |
| 28 | 2017 - Q1 (2017-03-31) | $380,795,000 | 4.31% | 15,311,400 | $24.32 |
| 29 | 2016 - Q4 (2016-12-31) | $357,044,000 | 4.54% | 16,506,900 | $21.82 |
| 30 | 2016 - Q3 (2016-09-30) | $409,638,000 | 4.66% | 17,211,700 | $23.86 |
| 31 | 2016 - Q2 (2016-06-30) | $540,529,000 | 5.64% | 23,129,200 | $21.63 |
| 32 | 2016 - Q1 (2016-03-31) | $422,843,000 | 4.44% | 22,479,700 | $17.57 |
| 33 | 2015 - Q4 (2015-12-31) | $450,506,000 | 4.07% | 24,430,900 | $17.92 |
| 34 | 2015 - Q3 (2015-09-30) | $393,958,000 | 3.98% | 24,007,200 | $17.09 |
| 35 | 2015 - Q2 (2015-06-30) | $383,736,000 | 3.2% | 21,680,000 | $17.87 |
| 36 | 2015 - Q1 (2015-03-31) | $239,820,000 | 2.04% | 13,511,000 | $15.80 |
| 37 | 2014 - Q4 (2014-12-31) | $4,240,000 | 0.04% | 320,000 | $12.78 |
| 38 | 2014 - Q3 (2014-09-30) | $3,209,000 | 0.03% | 271,700 | $12.59 |
| 39 | 2014 - Q2 (2014-06-30) | $3,470,000 | 0.04% | 271,700 | $13.00 |
| 40 | 2014 - Q1 (2014-03-31) | $3,673,000 | 0.04% | 271,700 | $13.13 |
| 41 | 2013 - Q4 (2013-12-31) | $0 | 0% | 0 | $11.81 |
| 42 | 2013 - Q3 (2013-09-30) | $1,996,000 | 0.03% | 170,000 | $10.82 |
| 43 | 2013 - Q2 (2013-06-30) | $0 | 0% | 0 | $8.48 |
| 44 | 2013 - Q1 (2013-03-31) | $3,037,000 | 0.07% | 388,800 | $7.15 |
| 45 | 2012 - Q4 (2012-12-31) | $3,725,000 | 0.11% | 650,000 | $5.49 |
| 46 | 2012 - Q3 (2012-09-30) | $3,731,000 | 0.1% | 650,000 | $5.52 |
| 47 | 2012 - Q1 (2012-03-31) | $3,887,000 | 0.11% | 650,000 | $5.90 |
| 48 | 2011 - Q4 (2011-12-31) | $3,471,000 | 0.11% | 650,000 | $5.52 |
| 49 | 2011 - Q3 (2011-09-30) | $3,842,000 | 0.14% | 650,000 | $6.57 |
| 50 | 2011 - Q2 (2011-06-30) | $8,292,000 | 0.15% | 1,200,000 | $7.06 |
| 51 | 2011 - Q1 (2011-03-31) | $8,628,000 | 0.29% | 1,200,000 | $7.23 |
| 52 | 2010 - Q4 (2010-12-31) | $9,084,000 | 0.32% | 1,200,000 | $6.70 |
The displayed share prices are average quarterly stock market prices.